<DOC>
	<DOCNO>NCT00667654</DOCNO>
	<brief_summary>This study evaluate dosing regimen 4975 term safety tolerability deliver intra-articular injection knee . Secondary objective explore efficacy 4975 term onset , extent duration pain relief .</brief_summary>
	<brief_title>Safety Tolerability 4975 Treatment Moderate Severe Knee Pain Due Osteoarthritis ( OA )</brief_title>
	<detailed_description>This single site study . The study drug , 4975 , administer various dose regimen intra-articular injection follow observation period 12 week . Pain treat knee assess , administration study drug .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Male female patient age 40 year . Body mass index ( BMI ) 35 less . History OA knee least 1 year experience pain target area least six month . XRay target knee . Willing able complete study procedure . Female patient pregnant lactate plan get pregnant . Clinically significant form joint disease OA . Medical condition could adversely impact patient 's participation , safety affect conduct study . Prior major trauma target knee major surgery partial total knee arthroplasty . Arthroscopic surgery target knee within 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Osteoarthritis , Knee</keyword>
</DOC>